{
    "id": "mda",
    "name": { "ja": "メチレンジオキシアンフェタミン", "en": "Methylenedioxyamphetamine" },
    "IUPAC_name": "1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine",
    "aliases": [
        "Tenamfetamine",
        "MDA",
        "3,4-メチレンジオキシアンフェタミン",
        "3,4-Methylenedioxyamphetamine",
        "Sass",
        "Sassafras",
        "Ecstasy",
        "エクスタシー",
        "XTC",
        "罰"],
    
    "pubchem_cid": "1614",
    "categories": ["エンタクトジェン", "サイケデリック", "中枢神経刺激薬"],
    "legal": {
        "jp": {
            "status": "麻薬",
            "lastReviewed": "2025-12-16"
        }
    },
    "summary": "低用量ではエンタクトジェンとして高用量では幻覚剤として作用するアンフェタミン誘導体",
    "warnings": [
        "高体温・脱水のリスク",
        "SSRIとの相互作用"
    ],
    "effects": [
        "共感・愛情の増加",
        "感覚の強化",
        "エネルギー増加",
        "社交性の向上",
        "外部幻覚",
        "内部幻覚"
    ],
    "external_resources": {
        "experiences": {
            "label": "Erowid: MDA Experience Vault",
            "url": "https://www.erowid.org/experiences/subs/exp_MDA.shtml"
        },
        "dosage_duration": {
            "label": "TripSit: MDMA",
            "url": "https://tripsit.me/factsheets/mda"
        }
    }

}
